Free Essay

Stability of Refrigerated and Frozen Drugs

In:

Submitted By johndoe123abc
Words 5272
Pages 22
Detail-Document #241001
−This Detail-Document accompanies the related article published in−

PHARMACIST’S LETTER / PRESCRIBER’S LETTER
October 2008 ~ Volume 24 ~ Number 241001

Stability of Refrigerated and Frozen Drugs
—Chart modified November 2008— (Based on U.S. product labeling and relevant studies) Failure to follow storage recommendations of pharmaceutical products can result in subpotent products and potentially, therapeutic failure.1-3 In addition, hundreds of thousand of medications are discarded each year because of improper storage conditions resulting in millions of dollars wasted.1,2 This can occur for a variety of reasons including improper shipping, failure to refrigerate or freeze a product upon receipt or after use, and in the event of a power failure. It is important to recognize when pharmaceutical products have not been stored according to the manufacturer’s specifications and take appropriate action. Depending on the product, lot number and expiration date, time of exposure to temperatures outside of the recommended range and actual temperature of exposure, some medications may be deemed suitable for administration while others should be discarded. The following chart provides general guidelines for the room temperature stability of common medications and vaccines which are stored in the refrigerator or freezer. However, if a pharmaceutical product has not been stored according to the recommended conditions, it is important to contact the manufacturer and provide the specifics (lot number, expiration date, exposure temperature, length of time) to determine if the product is viable. Continue to the end of this chart for helpful tips on what to do during a power failure or when there is a potential for flooding. • For a listing of Anti-infective Suspensions and their stability after reconstitution, see Detail-Document #231107 • For a listing of Insulin Products and their storage/stability information, see Detail-Document #220910

Generic name (Brand Name)*
Adalimumab (Humira)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Abbott Laboratories 800-633-9110 Pfizer 800-438-1935

Refrigerate at 36º to 46ºF (2º to 8ºC).

Alprostadil injection (Caverject solution)

Refrigerate 40 mcg strength at 36º to 46º F After dispensing 40 mcg strength: (2º to 8ºC) until dispensed. Three months at or below 25°C (77°F). (Store the 5, 10, and 20 mcg strengths at or below 77°F [25°C]). Refrigerate at 36º to 46º F (2º to 8ºC). 14 days.

Alprostadil urethral suppository (Muse)

Vivus, Inc. 650-934-5200
More. . .

Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 2 of 17)

Generic name (Brand Name)*
Amphotericin B (Amphocin, others)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER

Manufacturer Contact Information (Quality Control)

Azithromycin ophthalmic (Azasite)

Refrigerate at 36º to 46ºF (2º to 8ºC) before reconstitution (lyophilized powder).. After reconstitution, refrigerated solution (5 mg/mL concentration, diluted with Sterile Water for Injection) stable for one week. Refrigerate at 36º to 46º F (2º to 8ºC).

24 hours (reconstituted solution at Pfizer concentration of 5 mg/mL, diluted with 800-438-1935 Sterile Water for Injection).

Once the bottle is opened, store at 2° to Inspire Pharmaceuticals 25°C (36° to 77°F) for up to 14 days. 888-881-4696 Discard after 14 days. Contact manufacturer.*** Off-label§ information indicates that unopened bottles left out of refrigerator are stable (up to 86ºF or 30ºC) for up to six days or less, one time only.14 60 days. Johnson and Johnson Wound Management 888-REGRANEX

Becaplermin (Regranex)

Refrigerate at 36º to 46ºF (2º to 8ºC). Do not freeze.

Benzoyl peroxide/clindamycin (Duac) Calcitonin nasal (Fortical)

Refrigerate at 36º to 46ºF (2º to 8ºC). Do not freeze. Refrigerate unopened bottle at 36º to 46º F (2º to 8ºC).

Stiefel Labs 888-500-3376 Upsher-Smith Laboratories 763-315-2000

After opening, store bottle in use in an upright position for up to 30 days at 68o to 77°F (20o to 25°C). Excursions permitted to 59°F to 86°F (15° to 30°C). Off-label§ information indicates that unopened bottles left out of refrigerator (up to 77oF or 25oC) in the pharmacy for seven days or less can be safely dispensed to the patient.4 Contact manufacturer.***

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 3 of 17)

Generic name (Brand Name)*
Calcitonin injectable (Miacalcin) Calcitonin nasal (Miacalcin)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.*** Opened bottle may be stored at 59oF to 86oF (15o to 30oC) in upright position for 35 days.

Manufacturer Contact Information (Quality Control) Novartis 888-669-6682 Novartis 888-669-6682

Refrigerate unopened bottle at 36º to 46º F (2º to 8ºC). Refrigerate unopened bottle at 36º to 46º F (2º to 8ºC).

Chlorambucil (Leukeran)

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained at up to 86oF (30oC) for up to one week.5

GlaxoSmithKline 866-475-8222

Darbepoetin alfa (Aranesp)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Amgen 800-772-6436

Desmopressin (DDAVP Rhinal Tube) Dinoprostone cervical gel (Prepidil)

Refrigerate at 36º to 46º F (2º to 8ºC).

Up to three weeks.

Sanofi Aventis 908-243-6000 Pfizer 800-438-1935

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained for 24 hours.6 Up to 24 hours. Contact manufacturer.*** Off-label§ information indicates stable when maintained for up to 48 cumulative hours at a temperature up to 86oF (30oC).7

Dornase alfa (Pulmozyme)

Refrigerate at 36º to 46º F (2º to 8ºC).

Genentech 650-225-1000

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 4 of 17)

Generic name (Brand Name)*
Dronabinol (Marinol)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.*** Off-label§ information indicates stable when maintained at room temperature 77oF (25oC) for 24 months.8 Contact manufacturer.*** Contact manufacturer.*** Off-label§ information indicates the following stability data when maintained at room temperature up to 86ºF (30ºC): Single-dose vial – 14 days.15 Unopened multi-dose vial – seven days.15 After dispensing, store at room temperature below 77°F (25ºC) for up to six months. After dispensing, store at 77°F (25°C) for up to four months; excursions permitted to 59° to 86°F (15° to 30°C). Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Solvay Pharmaceuticals 770-578-9000

Refrigerate at 36º to 46º F (2º to 8ºC) or store in a cool environment between 46°F to 59°F (8°C to 15°C).

Epoetin alfa (Epogen) Epoetin alfa (Procrit)

Refrigerate at 36º to 46ºF (2º to 8ºC). Refrigerate at 36º to 46ºF (2º to 8ºC).

Amgen 800-772-6436 Ortho Biotech 888-227-5624

Estradiol/norethindrone acetate transdermal system (CombiPatch) Etonogestrel/ethinyl estradiol vaginal ring (NuvaRing) Estramustine (Emcyt)

Prior to dispensing, refrigerate at 36º to 46ºF (2º to 8ºC). Refrigerate at 36º to 46ºF (2º to 8ºC).

Novartis 888-669-6682 Organon 877-688-2746 Pfizer 800-438-1935 Immunex Corporation 888-436-2735

Refrigerate at 36º to 46ºF (2º to 8ºC).

Etanercept injection (Enbrel)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Etoposide capsules (VePesid)

Prior to dispensing, refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.*** However, one reference suggests:1 Vial – seven days.1 Prefilled syringe – four days.1,16 Contact manufacturer.***

Bristol-Myers Squibb 609-897-2000
More. . .

Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 5 of 17)

Generic name (Brand Name)*
Exenatide (Byetta)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER After first use, store at a room temperature not to exceed 77°F (25°C). Discard after 30 days. Stable at room temperature for up to 24 hours. Store at room temperature 68° to 77°F (20° to 25°C). Off-label§ information indicates stable when maintained at room temperature for up to 6 months.9 Contact manufacturer.*** Off-label§ information indicates oral solution stable for seven days at temps up to 86oF (30oC).6 One month at room temperature of 59o to 86oF (15o to 30oC). Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Amylin Pharmaceuticals 800-349-8919

Prior to first use, refrigerate at 36º to 46º F (2º to 8ºC). Do not freeze.

Filgrastim (Neupogen)

Refrigerate at 36º to 46º F (2º to 8ºC).

Amgen 800-772-6436 Schering Corporation 800-222-7579

Formoterol (Foradil)

Prior to dispensing, refrigerate at 36º to 46º F (2º to 8ºC).

Gabapentin oral suspension (Neurontin)

Refrigerate at 36º to 46º F (2º to 8ºC).

Pfizer 800-438-1935

Glatiramer acetate injection (Copaxone) Interferon alfacon-1 (Infergen) Interferon beta-1a (Avonex)

Refrigerate at 36º to 46º F (2º to 8ºC).

Teva Neuroscience 888-838-2872 Three Rivers Pharm. 724-778-6100 Biogen Idec 800-456-2255

Refrigerate at 36º to 46ºF (2º to 8ºC).

Refrigerate unreconstituted vial of lyophilized powder at 36º to 46ºF (2º to 8ºC).

Lyophilized powder vial – 30 days. Prefilled syringes – seven days.

Interferon beta-1a (Rebif)

Refrigerate at 36º to 46º F (2º to 8ºC).

30 days.

Pfizer 800-438-1935
More. . .

Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 6 of 17)

Generic name (Brand Name)*
Interferon gamma-1b (Actimmune)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Unopened vial should not be left at room temperature for a total time exceeding 12 hours prior to use. Vials stored at room temperature should not be returned to the refrigerator.

Manufacturer Contact Information (Quality Control) InterMune, Inc. 888-486-6411

Refrigerate at 36º to 46ºF (2º to 8ºC) immediately upon receipt to ensure optimal retention of physical and biochemical integrity. Do not freeze.

Latanoprost (Xalatan)

Prior to dispensing and opening, store unopened bottles in refrigerator at 36°F to 46°F (2°C to 8°C).

During shipment, unopened bottle stable at up to 104oF (40oC) for no more than eight days. After first use, store at a room temperature not to exceed 77°F (25°C) for up to 6 weeks. Off-label§ information indicates unopened bottle stable when maintained at continuous room temperature 77oF (25oC) for 12 months.6 Contact manufacturer.*** Contact manufacturer.*** Two months.

Pfizer 800-438-1935

Liotrix (Thyrolar ) Lopinavir/ritonavir solution (Kaletra)

Refrigerate at 36º to 46º F (2º to 8ºC). Refrigerate at 36º to 46ºF (2º to 8ºC) until dispensed. Stable until expiration date if stored in refrigerator.

Forest Pharmaceuticals 1-800-678-1605, ext. 66297 Abbott Laboratories 800-633-9110

Lorazepam intensol oral concentrate

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained at continuous room temperature 77oF (25oC) for 30 days.10

Roxane Laboratories 614-276-4000

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 7 of 17)

Generic name (Brand Name)*
Melphalan tablets (Alkeran)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.***

Manufacturer Contact Information (Quality Control) GlaxoSmithKline 888-825-5249

Refrigerate at 36º to 46º F (2º to 8ºC).

Octreotide (Sandostatin)

Refrigerate at 36º to 46º F (2º to 8ºC).

At room temperature (70°F to 86°F, 20°C to 30°C), stable for 14 days, when protected from light. Drug kit can remain at room temperature for 30 to 60 minutes prior to preparation. However, must be used immediately after preparation. Contact manufacturer.*** Off-label§ information indicates stable when maintained up to 77oF (25oC) for three months.11 24 hours. Contact manufacturer.*** Off-label§ information indicates the PegIntron Redipen (unreconstituted lyophilized powder) is stable when maintained up to 86oF (30oC) for one day. However, there is no data to address the re-refrigeration of the product after maintained in an unrefrigerated state.9

Novartis 888-669-6682

Octreotide injectable suspension (Sandostatin LAR)

Refrigerate at 36º to 46º F (2º to 8ºC).

Novartis 888-669-6682

Papain/urea topical (Ethezyme) PRODUCT DISCONTINUED BY MANUFACTURER Peginterferon alfa-2a (Pegasys) Peginterferon alfa-2b (PegIntron)

Refrigerate at 36º to 46ºF (2º to 8ºC) or in cool (46o to 59oF) place (8° to 15°C).

Ethex 800-321-1705

Refrigerate at 36º to 46º F (2º to 8ºC). PegIntron vials - Store at room temperature (77ºF [25ºC]; excursion permitted to 59ºF to 86ºF [15ºC to 30ºC]). After reconstitution, the solution should be used immediately, but may be stored up to 24 hours at 36° to 46°F (2° to 8°C). PegIntron Redipen - Refrigerate at 36º to 46º F (2º to 8ºC). After reconstitution, the solution should be used immediately, but may be stored up to 24 hours at 36° to 46°F (2° to 8°C).

Roche Laboratories 800-526-0625 Schering Corporation 800-222-7579

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 8 of 17)

Generic name (Brand Name)*
Pramlintide injection (Symlin) Promethazine suppositories (Promethegan) Proparacaine ophthalmic solution Ritonavir capsules (Norvir)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER 30 days.

Manufacturer Contact Information (Quality Control) Amylin Pharmaceuticals 800-349-8919 G & W Laboratories 908-753-2000 Akorn 847-279-6100 Abbott Laboratories 800-633-9110

Refrigerate at 36º to 46ºF (2º to 8ºC).

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.***

Refrigerate at 36º to 46ºF (2º to 8ºC) until dispensed. Stable until expiration date if stored in refrigerator. Prior to dispensing to the patient, refrigerate at 36º to 46ºF (2º to 8ºC). Refrigerate at 36º to 46ºF (2º to 8ºC). Refrigerate at 36º to 46º F (2º to 8ºC). Minimize time out of refrigerator during use. Refrigerate at 36º to 46º F (2º to 8ºC).

30 days.

Sinecatechins (Veregen)

After dispensing, can be stored at room temperature. Up to 15 days. Contact manufacturer.***

Doak Dermatologics 800-929-9300 Wyeth Pharmaceuticals 800-395-9938 Eli Lilly 800-545-5979 Novartis 888-669-6682

Sirolimus solution (Rapamune) Teriparatide (Forteo)

Tobramycin for oral inhalation (Tobi)

Opened or unopened pouches may be stored at room temperature (up to 77ºF or 25ºC) for up to 28 days. Contact manufacturer.*** Off-label§ information indicates stable when maintained up to 77ºF (25ºC) for two weeks. However, due to slight changes in pH (no change in potency), ocular stinging or discomfort may occur.17

Trifluridine (Viroptic)

Refrigerate at 36º to 46º F (2º to 8ºC).

King Pharmaceuticals 800-776-3637

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 9 of 17)

Generic name (Brand Name)*

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER

Manufacturer Contact Information (Quality Control)

Vaccines
Diphtheria, tetanus toxoids (DT) (pediatric) Refrigerate at 36º to 46ºF (2º to 8ºC). Contact manufacturer.*** Sanofi Pasteur 800-822-2463

Tetanus, diphtheria toxoids (Td) (adult) (Decavac)

Diphtheria, tetanus toxoids, acellular pertussis vaccine (DTaP) (pediatric) (Tripedia, Daptacel)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Sanofi Pasteur 800-822-2463

Diphtheria, tetanus toxoids, acellular pertussis vaccine (DTaP) (pediatric) (Infanrix)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 72 hours (Infanrix).12 Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 72 hours (Pediarix).12

GlaxoSmithKline 866-475-8222

Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B vaccine, inactivated polio vaccine (DTaP/HepB/IPV) (pediatric) (Pediarix)

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 10 of 17)

Generic name (Brand Name)*
Tetanus toxoid, reduced, diphtheria toxoids, acellular pertussis vaccine (Tdap) (adult) (Boostrix) Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine (pediatric) (Pentacel) Haemophilus influenzae type B conjugate vaccine (Hib) (PedvaxHIB) Haemophilus influenzae type B conjugate vaccine (Hib) (ActHIB) Haemophilus influenzae type B conjugate (Hib) and hepatitis B vaccines (Comvax) Hepatitis A vaccine (Havrix)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46ºF to 77ºF (above 8ºC to 25ºC) for 72 hours (Boostrix).12 Contact manufacturer.***

Manufacturer Contact Information (Quality Control) GlaxoSmithKline 866-475-8222

Refrigerate at 36º to 46ºF (2º to 8ºC)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Sanofi Pasteur 800-822-2463

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Merck 800-637-2590

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Sanofi Pasteur 800-822-2463

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Merck 800-637-2590

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 72 hours.12

GlaxoSmithKline 866-475-8222

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 11 of 17)

Generic name (Brand Name)*
Hepatitis A vaccine (Vaqta)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Merck 800-637-2590

Refrigerate at 36º to 46ºF (2º to 8ºC).

Hepatitis A and Hepatitis B vaccine (Twinrix)

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.*** Off-label information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 72 hours (Twinrix).12 Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 72 hours.12 Contact manufacturer.***

GlaxoSmithKline 866-475-8222

Hepatitis B vaccine (Engerix-B)

Refrigerate at 36º to 46ºF (2º to 8ºC).

GlaxoSmithKline 866-475-8222

Hepatitis B vaccine (Recombivax HB)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Merck 800-637-2590

Human papillomavirus (Types 6, 11, 16, 18) vaccine (Gardasil)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Merck 800-637-2590

Inactivated polio vaccine (IPV) (IPOL)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Sanofi Pasteur 800-822-2463

Influenza virus vaccine, types A and B (Afluria)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

CSL Limited 888-4FLU-OFF

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 12 of 17)

Generic name (Brand Name)*
Influenza virus vaccine, types A and B (FluLaval)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.***

Manufacturer Contact Information (Quality Control) GlaxoSmithKline 866-475-8222

Refrigerate at 36º to 46ºF (2º to 8ºC).

Influenza virus vaccine, types A and B (Fluarix)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

GlaxoSmithKline 866-475-8222

Influenza virus vaccine, types A and B (Fluvirin)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Novartis 800-244-7668

Influenza virus vaccine, types A and B (Fluzone)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Sanofi Pasteur 800-822-2463

Influenza attenuated influenza vaccine, live (LAIV) (FluMist)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.*** Off-label§ information indicates stable when maintained above 46oF to 77oF (above 8oC to 25oC) for 8 hours.13

MedImmune 800-949-3789

Measles, mumps. rubella vaccine (MMR) (M-M-R II)

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.***

Merck 800-637-2590

Diluent may be stored in the refrigerator or at room temperature. Do not freeze diluent.

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 13 of 17)

Generic name (Brand Name)*
Measles, mumps. rubella (MMR) and varicella vaccines (ProQuad)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Merck 800-637-2590

Store in freezer at an average temperature of 5°F (–15°C) or colder for up to 18 months. Can be stored in a refrigerator at 36º to 46ºF (2º to 8ºC) for up to 72 hours before reconstitution. Diluent may be stored in the refrigerator or at room temperature. Do not freeze diluent.

Meningococcal conjugate, groups A, C, Y and W-135 vaccine (MCV) (Menactra [also contains diphtheria toxoid], Menomune) Pneumococcal conjugate vaccine (Prevnar)

Refrigerate at 35º to 46ºF (2º to 8ºC). (Menomune single-dose vial should be used within 30 minutes of reconstitution) Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Sanofi Pasteur 800-822-2463

Contact manufacturer.***

Wyeth 800-999-9384

Pneumococcal polysaccharide vaccine (Pneumovax 23) Rotavirus vaccine (Rotarix)

Refrigerate at 36º to 46ºF (2º to 8ºC).

Contact manufacturer.***

Merck 800-637-2590

Refrigerate at 36º to 46ºF (2º to 8ºC). Diluent may be stored at room temperature.

After reconstitution, can be stored at room temperature up to 77°F (25°C) for 24 hours.

GlaxoSmithKline 866-475-8222

Rotavirus vaccine (RotaTeq)

Refrigerate at 36º to 46ºF (2º to 8ºC).
Administer as soon as possible after

Contact manufacturer.***

Merck 800-637-2590

removal from refrigerator.
More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 14 of 17)

Generic name (Brand Name)*
Varicella (chickenpox) vaccine (Varivax)

Recommended Storage**

Stability at Room Temperature** FOR SPECIFIC INFORMATION, CONTACT MANUFACTURER May be stored at refrigerator temperatures, 36º to 46º F (2º to 8ºC) for up to 72 hours prior to reconstitution. Vaccine stored in refrigerator must be used within 72 hours of removal from freezer. Other storage conditions are determined on a case-by-case basis. Contact manufacturer.***

Manufacturer Contact Information (Quality Control) Merck 800-9-VARIVAX

Store in freezer at 5º F (-15º C) or colder. Diluent may be stored in the refrigerator or at room temperature. Do not freeze diluent.

Typhoid vaccine, live oral (Vivotif) Zoster (shingles) vaccine (Zostavax)

Refrigerate at 36º to 46º F (2º to 8ºC).

Contact manufacturer.***

Berna Biotech, Ltd. 305-443-2900 Merck 800-9-VARIVAX

Store in freezer at 5º F (-15º C) or colder.

Contact manufacturer.***

Diluent may be stored in the refrigerator or at room temperature. Do not freeze diluent. * This table includes commonly used medications and vaccines. For those products not listed, consult the product information or pharmaceutical manufacturer for stability information at room temperature. ** Data based on information provided by prescribing information, unless otherwise indicated. The following PIs were used for this chart: Humira (January 2003), Caverject (October 2003), Muse (August 2003), Amphocin (October 2006), Azasite (December 2007), Regranex (May 2008), Duac (August 2002), Fortical (February 2004), Miacalcin injection (November 2002), Miacalcin nasal spray (June 2006), Leukeran (November 2006), Aranesp (August 2008), DDAVP Rhinal Tube (October 2007), Prepidil (July 2008), Pulmozyme (2008), Marinol (March 2008), Epogen (August 2008), Procrit (August 2008), CombiPatch (January 2005), NuvaRing (December 2007), Emcyt (June 2007), Enbrel (June 2008), VePesid (July 2006), Byetta (June 2008), Neupogen (September 2007), Foradil (June 2006), Neurontin oral solution (January 2007), Copaxone (November 2007), Infergen (July 2006), Avonex (November 2006), Rebif (April 2008), Actimmune (January 2007), Xalatan (November 2006), Thyrolar (April 2005), Kaletra (November 2007), Lorazepam Intensol oral concentrate (June 2007), Alkeran (November 2004), Sandostatin (September 2005), Sandostatin LAR (March 2008), Ethezyme (March 2006), Pegasys (January 2008), PegIntron (April 2008), Symlin (July 2008), Promethegan suppositories (June 2000), Proparacaine ophthalmic solution (July 2005), Norvir capsules (August 2008), Veregen (December 2007), Rapamune
More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 15 of 17)

(January 2008), Forteo (February 2008), Tobi (December 2007), Viroptic (October 2001), Diphtheria and Tetanus Toxoids, adsorbed (December 2005), Decavac (March 2004), Tripedia (March 2001), Daptacel (March 2008), Pentacel (June 2008), Infanrix (July 2003), Pediarix (March 2007), Boostrix (December 2005), PedvaxHIB (January 2001), ActHib (December 2005), Comvax (September 1996), Havrix (March 2008), Vaqta (May 2007), Twinrix (March 2007), Engerix-B (January 2007), Recombivax (May 2007), Gardasil (September 2008), IPOL (December 2005), Afluria (July 2008), FluLaval (July 2008), Fluarix (August 2008), Fluvirin (August 2008), Fluzone (August 2008), FluMist (July 2008), M-M-R II (May 2008), ProQuad (February 2008), Menactra (October 2007), Menomune (December 2005), Prevnar (December 2007), Pneumovax 23 (August 2008), RotaTeq (April 2008), Rotarix (April 2008), Varivax (November 2006), Vivotif (August 2006), Zostavax (July 2007). *** Room temperature stability determined on a case-by-case basis. Contact manufacturer and provide lot number and expiration date, length of time exposed to room temperature, maximum exposure temperature. § Off-label information is not reviewed or approved by the FDA.

Users of this document are cautioned to use their own professional judgment and consult any other necessary or appropriate sources prior to making clinical judgments based on the content of this document. Our editors have researched the information with input from experts, government agencies, and national organizations. Information and Internet links in this article were current as of the date of publication.

More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 16 of 17)

Safeguarding Pharmaceutical Products During Power Outages or Flooding
In the event of a power outage, there are a number of steps to take to minimize damage to pharmaceutical products. If the power goes out, the time of the power outage should be noted. During the power outage, refrigerator and freezer doors should not be opened. For products which are stored in the freezer, if the power outage continues for more than 24 hours, the products should be removed from the freezer and packed in dry ice. When the power is restored, the temperature in the refrigerator and freezer should be recorded, and monitored until the temperature has returned to the desired temperature. This allows the calculation of the duration of time the product was stored at a temperature outside of the product labeling and may enable calculations to be made by the product manufacturer, in consultation with FDA as necessary, about the continued potency of the involved products.3 When a flood is anticipated, if possible, pharmaceutical products should be moved out of areas which could accumulate flood water. If possible, elevate products stored on warehouse floors off the ground (e.g., on pallets). For those items on shelves, securely anchor the shelves to keep products dry. For refrigerated products, raise refrigerators onto platforms, if possible. 3 If flooding occurs, any product which was not sealed in airtight, waterproof bags should be considered contaminated and should be discarded.3
Users of this document are cautioned to use their own professional judgment and consult any other necessary or appropriate sources prior to making clinical judgments based on the content of this document. Our editors have researched the information with input from experts, government agencies, and national organizations. Information and Internet links in this article were current as of the date of publication. 2. Welte MS. Vaccines ruined by poor refrigeration. Washington Post, December 4, 2007. http://www.washingtonpost.com/wpdyn/content/article/2007/12/04/AR2007120400983.ht ml. (Accessed December 5, 2007). Food and Drug Administration. Impact of severe weather conditions on biological products. http://www.fda.gov/cber/weatherimpact.htm. (Accessed September 2, 2008). Personal communication. Bethany Z. Dimaculangan, Pharm.D. Medical Information. Upsher-Smith Laboratories. Maple Grove, MN 55369. September 12, 2008. Personal communication. Jacquelyn Collins. Medical Information. GlaxoSmithKline. Philadelphia, PA 19101. September 12, 2008. Personal communication. Prachi Parmar, R.Ph. Medical Information. Pfizer. New York, NY 100017. September 12, 2008. Personal communication. Deborah Bialy. Corporate Quality Product Support. Genentech. South San Francisco, CA 94080. September 12, 2008. Personal communication. Leah Bernstein, Ph.D. Medical Information Department. Solvay Pharmaceuticals. Marletta, GA 30062. September 15, 2008. Personal communication. Maleeha Ansari, Pharm.D. Global Medical Information. Schering Corporation. Kenilworth, NJ 07033. September 15, 2008. Personal communication. Technical Product Information Department. BI Roxane. Columbus, OH 43216. September 15, 2008. Personal communication. Michelle Kraus, Pharm.D., Medical Communications. KV Pharmaceutical. St. Louis, MO 63043. September 15, 2008. Personal communication. Jessie Li, Pharm.D. Vaccine and Anti-infectives Team. GlaxoSmithKline. Philadelphia, PA 19101. September 12, 2008. Personal communication. Gregory M. Susla, Pharm.D., FCCM. MedImmune. Gaithersburg, MD 20878. September 11, 2008. Personal communication. Gloria Rios-Kretvix. Customer Communications Center. Centocor Ortho Biotech. Raritan, NJ 08869. September 23, 2008. Personal communication. Diane Butner RN Scientific Affairs. Ortho-McNeil Janssen. Raritan, NJ 08869. September 23, 2008. Personal communication. Amgen Canada. Mississauga, Ontario L5N 0A4. 866-502-6436. September 19, 2008. Personal communication. Donna Clark. Information Specialist II. Professional Information Services. King Pharmaceuticals. Bristol, TN 37620. September 23, 2008.

3.

4.

5. 6. 7. 8.

9. 10. 11. 12. 13. 14. 15. 16. 17.

Project Leader in preparation of this DetailDocument: Neeta Bahal O’Mara, Pharm.D., BCPS

References
1. Cohen V, Jellinek SP, Teperikidis L, et al. Roomtemperature stability of medications labeled for refrigeration. Am J Health Syst Pharm 2007;64:17115.

Cite this Detail-Document as follows: Stability of refrigerated and frozen drugs. Pharmacist’s Letter/Prescriber’s Letter 2008;24(10):241001. More. . .
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312 Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #241001: Page 17 of 17)

Evidence and Advice You Can Trust…
3120 West March Lane, P.O. Box 8190, Stockton, CA 95208 ~ TEL (209) 472-2240 ~ FAX (209) 472-2249
Copyright © 2008 by Therapeutic Research Center – Posted with permission CR09312

Subscribers to Pharmacist’s Letter and Prescriber’s Letter can get Detail-Documents, like this one, on any topic covered in any issue by going to www.pharmacistsletter.com or www.prescribersletter.com

Similar Documents

Premium Essay

Study on Cold Chain Logistics

...maintaining ideal storage conditions for perishables products from the point of origin to the point of consumption in the food supply chain. Background Cold Chain Logistics is the logistics system that provides ideal condition to the temperature sensitive perishable goods from the point of origin to the point of consumption through thermal and refrigerated packaging methods and the logistical planning to protect the integrity of these shipments. The Cold Chain logistics infrastructure generally consists of: Pre-cooling facilities, Cold storage, Refrigerated Carriers, Packaging, Warehousing, Information Management System, Traceability and Financial & Insurance Institution. A Cold Chain is a temperature controlled supply chain which begins at pre-cooling stage prior to shipping. It involves a temperature and moisture controlled transportation and storage of refrigerated goods and frozen goods. With the growing demand of the fast food, ready meal and frozen products, Logistics organization are seeking for better cold chain solutions. Organizations are using several food temperature levels to suit the different food items. Frozen, cold chilled, medium chilled, exotic chilled are some of the frequently used nomenclature with specified product range, depending on the products, weather it is a meat, or banana, or potatoes, or ice-cream. The success of implementing cold chain management involves continual monitoring of product temperature throughout distribution and having appropriate...

Words: 11747 - Pages: 47

Premium Essay

Kellogg (K) vs. Kraft (Kft)

... 5. Balance Sheet f. Kraft xii. Balance Sheet xiii. Statement of Income xiv. Statement of Cash Flows V. References I. Introduction This analysis on Kraft (KRFT) and Kellogg (K) will include multiple facets.Kraft Foods Group, Inc. operates as a consumer packaged food and beverage company. It is also one of the largest company in the North America and the second largest in the world. It operates through six segments: Cheese, Refrigerated Meals, Beverages, Meals & Desserts, Enhancers & Snack Nuts, and Canada. The company provides natura, cream, processed, grated and shredded, and cottage chesses, as well as sour creams; cold cuts, hot dogs, bacons, and protein packs; lunch combinations, pickles, and meat alternatives; coffees, hot beverage systems, packaged juice drinks, powdered beverages, and liquid concentrates; and refreshment beverages. It also offers macaroni and cheese dinners, shells and cheese dinners, dry packaged desserts, refrigerated gelatin and pudding snacks,...

Words: 1753 - Pages: 8

Premium Essay

Junior Accountant

...Module 3 – Assignment 1 Practice Case Examination Backgrounder The background information relating to the Case Examination (Backgrounder) is provided to candidates in advance of the examination date. The Backgrounder contains information about both the company and the industry involved in the case. Candidates are expected to familiarize themselves with this information in preparation for the analysis that will be required during the Case Examination. Candidates should note that they will not be allowed to bring any written material, including the advance copy of this Backgrounder, into the examination centre. A new copy of this Backgrounder, together with additional information about the company and a supplement of formulae and tables, will be provided at the writing centre for the Case Examination. Only the following models of calculators are authorized for use during the Case Examination: 1. Texas Instruments 2. Hewlett Packard 3. Sharp TI BA II Plus (including the professional model) HP 10bII+ (or HP 10bll) EL-738C (or EL-738) Candidates are reminded that no outside research on the industry related to this case is required. Examination responses will be evaluated on the basis of the industry information provided in the Backgrounder and the question paper (Additional Information). © 2013 The Society of Management Accountants of Canada. All rights reserved. ®/™ Registered Trade-Marks/Trade-Marks are owned by The Society of Management Accountants of Canada. No part of this...

Words: 6979 - Pages: 28

Premium Essay

L&T Cement

...MIHIR A. DESAI VINCENT DESSAIN ANDERS SJÖMAN Nestlé and Alcon—The Value of a Listing Wolfgang Reichenberger, Chief Financial Officer (CFO) at Swiss food giant Nestlé, and Francisco Castañer, Executive Vice President (EVP), stepped into the offices of Peter Brabeck-Letmathe, Chief Executive Officer (CEO). On this day in early September 2001, they had important business to discuss with the company’s CEO. As EVP, Castañer was responsible for the non-food business of the Nestlé Group worldwide. Although Nestlé was primarily known for its food brands—such as Nescafé, Perrier and Buitoni—the company had some select activities in other sectors. Its two largest non-food holdings were in fullyowned eye-care company Alcon, a producer of ophthalmic drugs, equipment for ocular surgery, and contact lens solutions, and a large stake in cosmetics giant L'Oréal. For a while now, Nestlé had discussed carving out a part of Alcon for a public listing. The larger question then, that Reichenberger and Castañer wanted to discuss with Brabeck, was what effect a carve-out would have on Nestlé’s overall valuation. Assuming further that they did list Alcon, two other questions followed suit. First, how should they arrive at an appropriate valuation of Alcon? Second, on what stock exchange should they list their Texas-based, but Switzerland-incorporated, subsidiary: in New York or Zürich? Nestlé, The World’s Largest Food Company At the beginning of the new millennium, Nestlé was the world’s number one...

Words: 8260 - Pages: 34

Premium Essay

General Mills Earnings

...General Mills 2014 ANNUAL REPORT PUTTING THE CONSUMER Our Fiscal 2014 Financial Highlights In millions, except per share and return on capital data 52 weeks ended 52 weeks ended May 25, 2014 May 26, 2013 Change Net Sales Adjusted Segment Operating Profit* Net Earnings Attributable to General Mills Diluted Earnings per Share (EPS) Adjusted Diluted EPS, Excluding Certain Items Affecting Comparability* Return on Average Total Capital* Average Diluted Shares Outstanding Dividends per Share $17,910 $ 3,154 $ 1,824 $ 2.83 $ 2.82 11.6% 646 $ 1.55 $17,774 $ 3,223 $ 1,855 $ 2.79 $ 2.72 12.0% 666 $ 1.32 + 1% − 2% − 2% + 1% + 4% −40 basis pts. − 3% +17% N ET SA LE S Dollars in millions 2010 201 1 2012 2013 2014 14,636 14,880 16,658 17,774 17,910 A DJ USTE D S E G M E NT O PE R ATI N G PRO F IT * Dollars in millions 2010 201 1 2012 2013 2014 2,854 2,946 3,012 3,223 3,154 A DJ USTE D D I LUTE D E A R N I N G S PE R S H A R E * Dollars 2010 201 1 2012 2013 2014 2.31 2.48 2.56 2.72 2.82 D I V I D E N DS PE R S H A R E Dollars 2010 201 1 2012 2013 2014 0.96 1.12 1.22 1.32 1.55 *See page 87 for discussion of non-GAAP measures. Putting the Consumer First At General Mills, our key strategy for growing our worldwide food businesses is to Put the Consumer First. We work to connect with consumers and develop deep insight into what they like to eat, where they shop for food, and how they approach cooking today. From product development to manufacturing...

Words: 48114 - Pages: 193

Premium Essay

Edlp, Hi-Lo, and Margin Arithmetic

...and the economy. Recently it is the "everyday low price" (EDLP) format that has experienced rapid growth and media popularity. The prototypical description of an EDLP pricing policy is as follows: The retailer charges a constant, lower everyday price with no temporary price discounts. These constant everyday prices at the EDLP outlet eliminate week-toweek price uncertainty and represent a contrast to the "HiLo" pricing of promotion-oriented competitors. The Hi-Lo retailer charges higher prices on an everyday basis but then runs frequent promotions in which prices are temporarily lowered below the EDLP level.' Discounters like Wal-Mart have led the EDLP wave and successfully encroached on the turf of supermarkets and department and drug stores by advertising that their everyday prices are "always the lowest" to be...

Words: 7731 - Pages: 31

Free Essay

Bad Bug Book

...Bad Bug Book   Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins                                              Introduction  Food safety is a complex issue that has an impact on all segments of society, from the general public to government, industry, and academia. The second edition of the Bad Bug Book, published by the Center for Food Safety and Applied Nutrition, of the Food and Drug Administration (FDA), U.S. Department of Health and Human Services, provides current information about the major known agents that cause foodborne illness. The information provided in this handbook is abbreviated and general in nature, and is intended for practical use. It is not intended to be a comprehensive scientific or clinical reference. Under the laws administered by FDA, a food is adulterated if it contains (1) a poisonous or otherwise harmful substance that is not an inherent natural constituent of the food itself, in an amount that poses a reasonable possibility of injury to health, or (2) a substance that is an inherent natural constituent of the food itself; is not the result of environmental, agricultural, industrial, or other contamination; and is present in an amount that ordinarily renders the food injurious to health. The first includes, for example, a toxin produced by a fungus that has contaminated a food, or a pathogenic bacterium or virus, if the amount present in the food may be injurious to health. An example of the second...

Words: 91823 - Pages: 368

Free Essay

Msc Student

...CH02CH19-Yarmush ARI 12 May 2011 ANNUAL REVIEWS 15:43 Further Annu. Rev. Chem. Biomol. Eng. 2011.2:403-430. Downloaded from www.annualreviews.org Access provided by Imperial College London on 01/18/16. For personal use only. Click here for quick links to Annual Reviews content online, including: • Other articles in this volume • Top cited articles • Top downloaded articles • Our comprehensive search Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges Francois Berthiaume,1 Timothy J. Maguire,1 ¸ and Martin L. Yarmush1,2 1 Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854; email: ireis@sbi.org 2 Center for Engineering in Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114 Annu. Rev. Chem. Biomol. Eng. 2011. 2:403–30 Keywords First published online as a Review in Advance on March 17, 2011 artificial organs, skin, cartilage, liver, stem cells The Annual Review of Chemical and Biomolecular Engineering is online at chembioeng.annualreviews.org Abstract This article’s doi: 10.1146/annurev-chembioeng-061010-114257 Copyright c 2011 by Annual Reviews. All rights reserved 1947-5438/11/0715-0403$20.00 The past three decades have seen the emergence of an endeavor called tissue engineering and regenerative medicine in which scientists, engineers, and physicians apply tools from a variety of fields to construct biological ...

Words: 6720 - Pages: 27

Premium Essay

Marine Terminal Operation

...Edition: 1.1 February 2002 Distance Education Course ML–302.5 Marine Terminal Operations Unit 1 Marine Terminals The three lessons in this unit will cover the topics of: • the role and function of marine terminals • terminal development • operational planning • civil engineering aspects of terminal design. Module B: Certificate in Maritime Logistics Diploma in Shipping Logistics—Jamaica Maritime Institute 1−1 Unit 1: Marine terminals Marine Terminal Operations Unit 1 ...........Activities and expectations Agenda To complete this unit, you will: • Read and study the text in this unit and any assigned passages in the Student Reader. • Apply the information by performing the Activities • Test yourself by doing the Practice Exercises and checking your answers. Resources There is no textbook for this course. All the information you require is in this Study Guide. In addition, your Student Manual lists some books that you may wish to read to expand your knowledge. Learning outcomes When you have completed this unit you will be able to: • • Explain some of the considerations in equipment selection. • Discuss the needs for storage areas. • Discuss safety and emergency response considerations. • 1−2 Describe the role and functions of marine terminals. List the broad categories of studies that are needed in planning a new terminal. Module B: Certificate in Maritime Logistics (Course...

Words: 74405 - Pages: 298

Premium Essay

7-11csr

...President Chain Store Corporation 2011 CSR Report President Chain Store Corporation 2011 CSR Report www.7-11.com.tw 7-ELEVEN 2011 CSR REPORT Content About This Report h i s re p o r t e n c o m p a s s e s t h e v i e w s a n d strategies of President Chain Store Corp. (PCSC) concerning key issues of sustainability in the retail industry and displays our current results and future plans, thereby providing a channel to communicate with our stakeholders. Meanwhile, we view this report as a strategic means of self-review and –assessment so that all results will produce a rolling multiplier effect, gradually achieving the ultimate goal of a happy enterprise and society. The 2011 Corporate Social Responsibility (CSR) repor t is the first to be issued by the PCSC in accordance with the Global Report Initiative’s thirdgeneration criteria (GRI G3). Its contents are based primarily on data from 2009 to 2010 (from Jan. 1st, 2009 to Dec. 31st, 2010), with B-Level application status and organization boundaries established according to the consolidated-statement principle. The primary scope of the performance presented in the current report is limited to PCSC operations in Taiwan. Data from other subsidiary companies are expected to be included gradually in future reports so as to present more complete information and carry out the verification of report. Content • Reporting Principles The core of this 2011 President Chain Store Corp. CSR report is ”Happiness,” with a...

Words: 27495 - Pages: 110

Premium Essay

Operations Research

...UNIT I INTRODUCTION ------------------------------------------------- Understanding Brand - What is a Brand? Brands are different from products in a way that brands are “what the consumers buy”, while products are “what concern/companies make”. Brand is an accumulation of emotional and functional associations. Brand is a promise that the product will perform as per customer’s expectations. It shapes customer’s expectations about the product. Brands usually have a trademark which protects them from use by others. A brand gives particular information about the organization, good or service, differentiating it from others in marketplace. Brand carries an assurance about the characteristics that make the product or service unique. A strong brand is a means of making people aware of what the company represents and what its offerings are.To a consumer, brand means and signifies: * Source of product * Delegating responsibility to the manufacturer of product * Lower risk * Less search cost * Quality symbol * Deal or pact with the product manufacturer * Symbolic device | | Brands simplify consumers purchase decision. Over a period of time, consumers discover the brands which satisfy their need. If the consumers recognize a particular brand and have knowledge about it, they make quick purchase decision and save lot of time. Also, they save search costs for product. Consumers remain committed and loyal to a brand as long as they believe...

Words: 34880 - Pages: 140

Premium Essay

Marketing Lecture

...1 March 30, 2003 To the reader: You are enrolled in a principles of marketing course. This publication is intended to supplement your lecture materials. As you read through the text, note that it is keyed to illustrations used in class. The course is divided into three sections. Section one covers introduction to marketing, consumer behavior, industrial buyer behavior, the marketing environment, where marketing fits into the organization, market segmentation, and product differentiation. Section two covers product and pricing. Section three covers promotion (sales) and distribution. As you read the book, consider that it is organized as follows: marketing and its environment (consumer behavior, industrial buyer behavior, marketing environment), product, pricing, promotion, and distribution. So, coverage begins with introductory concepts and proceeds into the marketing mix elements (product, price, promotion and place). You may wonder whether this book covers all aspects of marketing. No, it does not cover all aspects of marketing. You will find only basic concepts herein. If you seek specific, contemporary examples of marketing concepts, check out a traditional textbook from the library or purchase a recent edition from a used book store. Try the Perreault and McCarthy textbook (14th edition) or the Kotler and Armstrong textbook. Section I: Concepts of Marketing A. Who is a Marketer? Consider first that marketing is driven by people and their needs. It is people driven...

Words: 39450 - Pages: 158

Premium Essay

Infant Formula

...Infant Feeding in the Context of HIV FACILITATOR’S MANUAL TOSOUTH SOUTH THE SOUTH TO SOUTH PARTNERSHIP FOR COMPREHENSIVE FAMILY HIV CARE AND TREATMENT PROGRAM (S2S) South Africa has the largest HIV burden of any country in the world, with an estimated 5.7 million people living with the virus. Women and children remain at the centre of the pandemic in terms of transmission, vulnerability and potential for impact. To continue to build on the existing successes of South Africa’s antiretroviral (ARV) program, the capacity for HIV disease management must be enhanced. It is essential that HIV disease management transition from an individual case management to a family-centred and chronic-care approach targeting and prioritising pregnant women and children. Enrolling pregnant women and children into HIV care and treatment early and regularly can prevent new HIV infections and reduce morbidity and mortality, effectively sustaining the quality of life of mothers, their children, and their families. The scale up of effective prevention of mother-to-child transmission (PMTCT) and paediatric ARV care and treatment programs are crucial in the fight against HIV but are challenged by many factors including perceived complexity of treating pregnant women and children, inadequate paediatric and PMTCT knowledge and clinical skills, lack of psychosocial and adherence support, delays in integrating PMTCT services with antenatal and child health management systems, and gaps in referral...

Words: 47026 - Pages: 189

Premium Essay

Impact of Trade on Egypt

...FINAL REPORT Impact of Trade and Economic Policy Reforms on Key Sectors of the Egyptian Economy PREPARED BY ATR Project SUBMITTED TO USAID/Cairo Ministry of Foreign Trade SUBMITTED BY Nathan Associates UNDER CONTRACT NO. PCE-I-00-98-00016-00 Task Order 827 2 April 2004 Contents Executive Summary Egypt’s Economy in Relation to the Global Marketplace Trade Policy and the International Trade Regime Impact of Trade Regime Changes on Subsectors Conclusions Next Steps 1. Introduction 2. Egypt’s Economy and Its Place in the Global Arena Egyptian Economy Today Structure of the Economy Labor force, Employment and Unemployment Macroeconomy and Balance of Payments Trade Patterns Macroeconomic and Trade Policy Reform Current Challenges Distinguishing Characteristics of Egypt’s Economy Water Resources and Growing Population Pressure Oil and Natural Gas Geographical Location Egyptian Culture Higher Education Socialism and Its Aftermath Egypt’s Comparative Advantage in the Global Economy Changing Global Economy Egypt’s Economy in Relation to Three Waves of Globalization Revealed Competitive Advantage Analysis v vi viii xi xiv xvi 1 5 5 5 7 8 10 12 13 14 14 16 16 16 17 18 19 19 22 25 II 3. Trade Policy and the International Trade Regime Current Trade Regime in Egypt Tariff Structure Non-tariff Barriers to Trade Multilateral, Regional, and Bilateral Agreements Multilateral Agreements Regional Agreements Bilateral Agreements Trade Regimes of Major Trading...

Words: 75620 - Pages: 303

Premium Essay

Manager

...Learning with Cases INTRODUCTION The case study method of teaching used in management education is quite different from most of the methods of teaching used at the school and undergraduate course levels. Unlike traditional lecture-based teaching where student participation in the classroom is minimal, the case method is an active learning method, which requires participation and involvement from the student in the classroom. For students who have been exposed only to the traditional teaching methods, this calls for a major change in their approach to learning. This introduction is intended to provide students with some basic information about the case method, and guidelines about what they must do to gain the maximum benefit from the method. We begin by taking a brief look at what case studies are, and how they are used in the classroom. Then we discuss what the student needs to do to prepare for a class, and what she can expect during the case discussion. We also explain how student performance is evaluated in a case study based course. Finally, we describe the benefits a student of management can expect to gain through the use of the case method. WHAT IS A CASE STUDY? There is no universally accepted definition for a case study, and the case method means different things to different people. Consequently, all case studies are not structured similarly, and variations abound in terms of style, structure and approach. Case material ranges from small caselets (a few paragraphs...

Words: 239776 - Pages: 960